Evidence map›Paper›PMID 35401570›Full record

ArticleFrontiers in immunology2022

Proteomic and Single-Cell Transcriptomic Dissection of Human Plasmacytoid Dendritic Cell Response to Influenza Virus.

Mustafa H Ghanem, Andrew J Shih, Houman Khalili, Emily G Werth, Jayanta K Chakrabarty, Lewis M Brown, Kim R Simpfendorfer, Peter K Gregersen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  7. Article
  8. Article
  9. Mixed Leukocyte Reaction Using Human Plasmacytoid Dendritic Cells and CD4Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mustafa H GhanemDepartment of Molecular Medicine, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
Andrew J ShihThe Institute of Molecular Medicine at The Feinstein Institutes for Medical Research, Manhasset, NY, United States.
Houman KhaliliThe Institute of Molecular Medicine at The Feinstein Institutes for Medical Research, Manhasset, NY, United States.
Emily G WerthQuantitative Proteomics and Metabolomics Center, Department of Biological Sciences, Columbia University, New York, NY, United States.
Jayanta K ChakrabartyQuantitative Proteomics and Metabolomics Center, Department of Biological Sciences, Columbia University, New York, NY, United States.
Lewis M BrownQuantitative Proteomics and Metabolomics Center, Department of Biological Sciences, Columbia University, New York, NY, United States.
Kim R SimpfendorferDepartment of Molecular Medicine, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
Peter K GregersenDepartment of Molecular Medicine, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United States.
Feinstein Institute for Medical Research · USColumbia University · US

Funding

The role of GLUT3 in the genetics of autoimmunity and immunometabolismK01AR071502 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI SIMPFENDORFER, KIM R · 2018 to 2022
$639k
6 · The paper itself

Abstract

Plasmacytoid dendritic cells [pDCs] represent a rare innate immune subset uniquely endowed with the capacity to produce substantial amounts of type-I interferons. This function of pDCs is critical for effective antiviral defenses and has been implicated in autoimmunity. While IFN-I and select cytokines have been recognized as pDC secreted products, a comprehensive agnostic profiling of the pDC secretome in response to a physiologic stimulus has not been reported. We applied LC-MS/MS to catalogue the repertoire of proteins secreted by pDCs in the unperturbed condition and in response to challenge with influenza H1N1. We report the identification of a baseline pDC secretome, and the repertoire of virus-induced proteins including most type-I interferons, various cytokines, chemokines and granzyme B. Additionally, using single-cell RNA-seq [scRNA-seq], we perform multidimensional analyses of pDC transcriptional diversity immediately

Indexed as

Influenza A Virus, H1N1 SubtypeInterferon Type IChromatography, LiquidCytokinesDendritic CellsHumansProteomicsTandem Mass SpectrometryTranscriptomeCytokinesInterferon Type Iinfluenza virusinterferonplasmacyotid DCssecretome and transcriptome analysissingle cell RNA seq

Identifiers

PMID35401570
PMCPMC8984281
OpenAlexW4225597915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.